Search Results

An Interview With Brian Whisenant, MD

The Medical Director of Intermountain Medical Center's Structural Heart Disease Program discusses the significance of mitral regurgitation, advances in imaging, and the latest PFO trials that aim to determine the best devices and patient populations for closure.

Current PFO and Migraine Trials

With the recent troubles concerning MIST, where do we go from here?

By Brian Whisenant, MD

Ask the Experts: What Is the Role of Mitral Repair in Heart Failure?

Experts discuss treatment strategies for patients with mitral regurgitation progressing to heart failure.

With William Weir, MD; Steven F. Bolling, MD; Brian Whisenant, MD; Nyal Borges, MD; Samir Kapadia, MD, FACC, FSCAI; Muath Bishawi, MD; and Donald D. Glower Jr, MD

Ask the Experts: What is the impact of the Watchman approval on structural practice? What are the roles of the electrophysiology and interventional cardiology physician?

By Dhanunjaya Lakkireddy, MD, FACC, FHRS, and Brian Whisenant, MD

Interventional Therapies for Heart Failure

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Structural and Valvular Update

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

Structural Disease Update

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Chief Medical Editor's Page

By Ted E. Feldman, MD, FSCAI